SEC Info - Angiodynamics Inc - ‘10-Q’ for 8/31/15

SEC Info℠

Home

Help

Please Sign In

Angiodynamics Inc – ‘10-Q’ for 8/31/15 – ‘EX-101.SCH’

On: Thursday, 10/8/15, at 4:36pm ET · For: 8/31/15 · Accession #: 1275187-15-22 · File #: 0-50761

  As Of               Filer                 Filing    For·On·As Docs:Size

10/08/15  Angiodynamics Inc                 10-Q        8/31/15   69:5.1M

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    371K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
46: R1          Document and Entity Information                     HTML     41K 
36: R2          Consolidated Statements of Income                   HTML     89K 
44: R3          Consolidated Statements of Comprehensive Income     HTML     50K 
48: R4          Consolidated Balance Sheets                         HTML    127K 
63: R5          Consolidated Balance Sheets (Parenthetical)         HTML     47K 
38: R6          Consolidated Statements of Cash Flows               HTML    103K 
43: R7          Consolidated Statement of Stockholders' Equity      HTML     70K 
32: R8          Consolidated Financial Statements                   HTML     30K 
25: R9          Inventories                                         HTML     32K 
64: R10         Goodwill and Intangible Assets                      HTML     75K 
50: R11         Accrued Liabilities                                 HTML     38K 
49: R12         Long Term Debt                                      HTML     30K 
54: R13         Income Taxes                                        HTML     59K 
55: R14         Share-Based Compensation                            HTML     30K 
53: R15         Earnings Per Share                                  HTML     33K 
56: R16         Segment and Geographic Information                  HTML     49K 
45: R17         Fair Value                                          HTML    138K 
47: R18         Marketable Securities                               HTML     53K 
52: R19         Commitments and Contingencies                       HTML     35K 
69: R20         Recently Issued Accounting Pronouncements           HTML     32K 
59: R21         Restructuring                                       HTML     24K 
40: R22         Inventories (Tables)                                HTML     31K 
51: R23         Goodwill and Intangible Assets (Tables)             HTML     70K 
42: R24         Accrued Liabilities (Tables)                        HTML     37K 
19: R25         Income Taxes (Tables)                               HTML     54K 
60: R26         Earnings Per Share (Tables)                         HTML     31K 
65: R27         Segment and Geographic Information (Tables)         HTML     44K 
28: R28         Fair Value (Tables)                                 HTML    131K 
27: R29         Marketable Securities (Tables)                      HTML     46K 
30: R30         Consolidated Financial Statements - Additional      HTML     70K 
                Information (Detail)                                             
31: R31         Acquisitions - Additional Information (Detail)      HTML     36K 
33: R32         Inventories - Schedule of Inventories (Detail)      HTML     30K 
18: R33         Goodwill and Intangible Assets - Additional         HTML     25K 
                Information (Detail)                                             
57: R34         Goodwill and Intangible Assets - Goodwill by        HTML     22K 
                Segment (Detail)                                                 
39: R35         Goodwill and Intangible Assets - Intangible Assets  HTML     57K 
                (Detail)                                                         
41: R36         Accrued Liabilities - Summary of Accrued            HTML     52K 
                Liabilities (Detail)                                             
22: R37         Long Term Debt - Additional Information (Detail)    HTML     77K 
68: R38         Income Taxes - Components of Income Tax             HTML     40K 
                Expense/(Benefit) (Detail)                                       
12: R39         Income Taxes - Additional Information (Detail)      HTML     31K 
34: R40         Income Taxes Net Operating Loss Carryforwards       HTML     45K 
                (Details)                                                        
62: R41         Share-Based Compensation (Details)                  HTML     29K 
21: R42         Earnings Per Share - Reconciliation of Basic to     HTML     28K 
                Diluted Weighted-Average Shares Outstanding                      
                (Detail)                                                         
26: R43         Segment and Geographic Information - Additional     HTML     22K 
                Information (Detail)                                             
29: R44         Segment and Geographic Information - Summary of     HTML     31K 
                Net Sales by Product Category (Detail)                           
37: R45         Segment and Geographic Information - Summary of     HTML     31K 
                Net Sales by Geographic Area (Detail)                            
17: R46         Fair Value - Additional Information (Detail)        HTML     21K 
24: R47         Fair Value - Fair Value of Assets and Liabilities   HTML     67K 
                Measured on a Recurring Basis (Detail)                           
14: R48         Fair Value - Fair Value Measurements Using          HTML     41K 
                Significant Unobservable Inputs (Detail)                         
61: R49         Fair Value - Summary Showing the Recurring Fair     HTML     53K 
                Value Measurements of the Contingent Consideration               
                Liability (Detail)                                               
20: R50         Fair Value - Summary Showing Reconciliation of the  HTML     25K 
                Contingent Payments (Detail)                                     
58: R51         Marketable Securities - Additional Information      HTML     23K 
                (Detail)                                                         
23: R52         Marketable Securities - Marketable Securities       HTML     34K 
                (Detail)                                                         
35: R53         Commitments and Continfencies - Additional          HTML     35K 
                Information (Detail)                                             
13: R54         Restructuring - Additional Information (Detail)     HTML     26K 
16: R55         Immaterial Corrections (Details)                    HTML    111K 
67: XML         IDEA XML File -- Filing Summary                      XML    120K 
15: EXCEL       IDEA Workbook of Financial Reports                  XLSX     63K 
 6: EX-101.INS  XBRL Instance -- ango-20150831                       XML   1.26M 
 8: EX-101.CAL  XBRL Calculations -- ango-20150831_cal               XML    187K 
 9: EX-101.DEF  XBRL Definitions -- ango-20150831_def                XML    507K 
10: EX-101.LAB  XBRL Labels -- ango-20150831_lab                     XML   1.25M 
11: EX-101.PRE  XBRL Presentations -- ango-20150831_pre              XML    786K 
 7: EX-101.SCH  XBRL Schema -- ango-20150831                         XSD    144K 
66: ZIP         XBRL Zipped Folder -- 0001275187-15-000022-xbrl      Zip    167K

‘EX-101.SCH’ — XBRL Schema — ango-20150831

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.angiodynamics.com/20150831" xmlns:ango="http://www.angiodynamics.com/20150831" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">

<xsd:import namespace="http://fasb.org/us-gaap/2014-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-roles/2014-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2014/elts/us-roles-2014-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-types/2014-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2014/elts/us-types-2014-01-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>

<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/currency/2014-01-31" schemaLocation="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/exch/2014-01-31" schemaLocation="http://xbrl.sec.gov/exch/2014/exch-2014-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>

<xsd:annotation>

<xsd:appinfo>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ango-20150831_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ango-20150831_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ango-20150831_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ango-20150831_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>

<link:roleType id="AccruedLiabilities" roleURI="http://www.angiodynamics.com/role/AccruedLiabilities">

<link:definition> 2105100 - Disclosure - Accrued Liabilities </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>